Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Prescription Drugs: Little Is Known About the Effects of Direct-to-Consumer Advertising

PEMD-91-19 Published: Jul 09, 1991. Publicly Released: Aug 12, 1991.
Jump To:

Highlights

Pursuant to a congressional request, GAO reviewed direct-to-consumer advertising (DTCA) of prescription drugs, focusing on: (1) its potential benefits or detriments; (2) consumer and physician attitudes toward DTCA and the confidence placed in this knowledge; and (3) existing research gaps regarding DTCA.

Full Report

Full Report (40 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Health Care
AdvertisingConsumer educationDrugsPharmaceutical industryPhysiciansPublic health researchSurveysPrescription drugsTelevisionPatient care